Kevin C-Johnson, Ph.D.

Postdoctoral Associate

Leverages genomic technologies to investigate brain tumor biology and disease evolution.

Visit The Verhaak Lab

About Kevin C. Johnson, Ph.D.

Dr. Johnson has a Ph.D. in Experimental and Molecular Medicine from Dartmouth where he received comprehensive training in quantitative and basic biomedical sciences. He has strong interest in the dynamic epigenomic landscape of glioma cells during disease progression and recurrence.

DOWNLOAD CV

Education and Experience

2016 – present Postdoctoral Research Fellow

The Jackson Laboratory for Genomic Medicine

2011 – 2016 Ph.D., Experimental and Molecular Medicine

Dartmouth College

2007 – 2011 B.S., Food Science and Technology,

University of Massachusetts – Amherst

Research HighlightJanuary 16, 2019
The rapid evolution of cancer cells under attack
JAX Associate Professor Jeff Chuang tracks the effects of chemotherapy on different subpopulations of cancer cells. The results indicate ways to improve therapy administration in human patients.
Press ReleaseJanuary 09, 2019
Linking therapy to an asthma-driving molecule
Armed with a $2.4 million grant from the National Institutes of Health, JAX Assistant Professor Adam Williams, Ph.D., is studying the role of molecules called long, non-coding RNAs in asthma.
Press ReleaseDecember 27, 2018
New Alzheimer's mouse models give insight into how human diversity affects disease onset
A new genetically diverse mouse population is opening possibilities for translational research into Alzheimer’s disease that accurately recreates human disease symptoms and progression.
Blog PostDecember 11, 2018
Nesting dolls and Narnia
Research has yielded fascinating discoveries in genomics, but just when it looks like we might come to a more complete understanding, we instead find more layers of complexity to explore.

Minute to UnderstandingJanuary 11, 2019
Minute to Understanding: What is gene therapy?
Mutations in our genes can cause life-threatening diseases, and sometimes there is no drug or surgery available for your doctor to prescribe. Enter gene therapy.
- Precision medicine
- Genetics and Genomics
Press ReleaseJanuary 08, 2019
JAX researcher lands Department of Defense grant to study endometriosis
Supported by a grant from the U.S. Department of Defense, Elise Courtois is researching the genetic mechanisms underlying endometriosis, a painful disease with no non-surgical treatment.
Research HighlightDecember 11, 2018
The unexpected advantages of outbred mice in research
Recently developed outbred mouse populations, such as the diversity outbred (DO) mice at The Jackson Laboratory (JAX), have created research options that parallel or even exceed human genetic diversity. Research with DO mice offers a full range of genetic diversity, and therefore more generalizability of responses across populations.
Blog PostNovember 27, 2018
Efficient and effective methods to use family history data for risk assessment
As 1 in 10 people are at increased risk for cancer, but often go undetected, knowing who these people are can lead to personalized management and better health outcomes.
- Cancer/Tumors
- Cancer

Kevin C. Johnson, Ph.D.

Postdoctoral Associate

About Kevin C. Johnson, Ph.D.

Education and Experience

Honors and Accomplishments

Selected Publications

The rapid evolution of cancer cells under attack

Linking therapy to an asthma-driving molecule

New Alzheimer's mouse models give insight into how human diversity affects disease onset

Nesting dolls and Narnia

Minute to Understanding: What is gene therapy?

JAX researcher lands Department of Defense grant to study endometriosis

The unexpected advantages of outbred mice in research

Efficient and effective methods to use family history data for risk assessment